XML 47 R57.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value Measurements (Details Textual) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 28, 2015
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Feb. 12, 2015
Dec. 31, 2014
Business Acquisition, Contingent Consideration [Line Items]              
Asset impairment charges       $ 0.0      
Changes in valuation techniques       0      
Reclassification of debt issuance costs   $ 47.5          
Contingent consideration obligations   301.9   $ 301.9     $ 200.0
Contingent consideration   0.0 $ 0.0 274.5 $ 0.0    
Current portion of contingent consideration obligations   479.5   479.5     $ 265.5
Convergence Pharmaceuticals              
Business Acquisition, Contingent Consideration [Line Items]              
Contingent consideration $ 274.5            
Potential future milestone payments           $ 450.0  
Discount rate 2.00%            
Current portion of contingent consideration obligations   $ 176.4   $ 176.4      
In-process research and development and other intangible assets           $ 424.6  
6.875% Senior Notes due 2018              
Business Acquisition, Contingent Consideration [Line Items]              
Senior Notes interest rate   6.875%   6.875%      
2.900% Senior Notes due 2020              
Business Acquisition, Contingent Consideration [Line Items]              
Senior Notes interest rate   2.90%   2.90%      
3.625% Senior Notes due 2022              
Business Acquisition, Contingent Consideration [Line Items]              
Senior Notes interest rate   3.625%   3.625%      
4.050% Senior Notes due 2025              
Business Acquisition, Contingent Consideration [Line Items]              
Senior Notes interest rate   4.05%   4.05%      
5.200% Senior Notes due 2045              
Business Acquisition, Contingent Consideration [Line Items]              
Senior Notes interest rate   5.20%   5.20%      
Adjustment for new accounting principle, early adoption | 6.875% Senior Notes due 2018              
Business Acquisition, Contingent Consideration [Line Items]              
Reclassification of debt issuance costs   $ 1.8